Dataset Open Access
Purification of Q23 and Q54 HTT and HTT-HAP40 from Sf9 2019/10/07
Harding, Rachel;
Hutchinson, Ashley;
Seitova, Alma;
Arrowsmith, Cheryl;
Edwards, Aled
Project: Biophysical investigation of purified HTT protein samples
Experiment: Purification of Q23 and Q54 HTT and HTT-HAP40 from Sf9
Date completed: 2019/10/07
Rationale: Purification of HTT and HTT-HAP40 Q23 and Q54 for different biophysical and functional analyses
Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
(930.7 kB)
| Name | Size | |
|---|---|---|
|
Purification of HTT and HTT-HAP40 Q23 and Q54 for different biophysical and functional analyses 20191007.docx
md5:4907cfe2b82647f8223e4473b775dafb |
600.0 kB | Download |
|
Purification of HTT and HTT-HAP40 Q23 and Q54 for different biophysical and functional analyses 20191007.pdf
md5:0cc10a664692cbffb6a11b4ccbe63e84 |
330.7 kB | Download |
58
33
views
downloads
| All versions | This version | |
|---|---|---|
| Views | 58 | 56 |
| Downloads | 33 | 32 |
| Data volume | 11.7 MB | 11.4 MB |
| Unique views | 56 | 54 |
| Unique downloads | 29 | 28 |
Indexed in
- Publication date:
- October 7, 2019
- DOI:
-
- Keyword(s):
- huntington's disease huntingtin protein purification
- Communities:
- License (for files):
- Creative Commons Attribution 4.0 International